Stanford University
Showing 701-710 of 1,496 Results
-
Paul B. Welander
Lead Scientist, Technology Innovation
BioPaul Welander is a Lead Scientist and Head of the Quantum Devices Department in the Technology Innovation Directorate at SLAC National Accelerator Laboratory. Paul’s research interests concern materials for quantum devices, from the study of materials-induced decoherence mechanisms in superconducting quantum bits, to the development of materials platforms that enable novel quantum technologies. He’s a researcher in both the Detector Microfabrication Facility and Nano-X, two new state-of-the-art cleanrooms at SLAC geared toward superconductor quantum device fabrication and rapid nano-prototyping, respectively. Paul also leads experiments at the Stanford Synchrotron Radiation Lightsource (SSRL) to characterize materials used in superconducting quantum devices and correlate those measurements with device performance and quantum decoherence rates. His expertise includes molecular beam epitaxy of metal-oxide heterostructures, superconducting device fabrication, and an array of materials characterization techniques including electron and x-ray diffraction, photoelectron spectroscopy, and scanning probe microscopy. Paul received his Ph.D. in physics from the University of Illinois at Urbana-Champaign, and holds Bachelors degrees from both Caltech and Occidental College. Prior to joining SLAC in 2012, he spent five years as a member of the technical staff at MIT Lincoln Laboratory.
-
Paula V. Welander
Senior Associate Dean for Research and Professor of Earth System Science
Current Research and Scholarly InterestsBiosynthesis of lipid biomarkers in modern microbes; molecular geomicrobiology; microbial physiology
-
Chad S. Weldy, M.D., Ph.D.
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe Weldy Lab studies how human genetic variation drives vascular dysfunction, inflammation, and cardiovascular disease. We integrate human genetics, epigenetics, single-cell genomics, RNA biology, and experimental models to define causal mechanisms and identify new therapeutic opportunities.
Led by Chad S. Weldy, MD, PhD, the lab focuses on questions at the intersection of cardiovascular genetics, vascular biology, and RNA-mediated regulation, with particular interest in smooth muscle cell phenotypic modulation, innate immune signaling, and mechanisms of disease susceptibility governed by epigenetic memory.
Our work is grounded in the idea that genetic discovery can do more than identify risk. It can reveal the biology that matters most and point toward more precise strategies for prevention and treatment.
https://weldylab.org/ -
Kevin Wells
Adm Svcs Admstr 2, Physics
Current Role at StanfordExecutive Director, Stanford Institute for Theoretical Physics
